Ignite Creation Date:
2024-05-05 @ 10:09 PM
Last Modification Date:
2024-10-26 @ 10:14 AM
Study NCT ID:
NCT01040871
Status:
COMPLETED
Last Update Posted:
2014-01-13
First Post:
2009-12-29
Brief Title:
Study of the Combination of VELCADE Rituximab Cyclophosphamide Doxorubicin and Prednisone or Rituximab Cyclophosphamide Doxorubicin Vincristine and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
Sponsor:
Millennium Pharmaceuticals Inc
Organization:
Millennium Pharmaceuticals Inc
Organization Data
Organization:
Millennium Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
26866138-LYM-2034
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Millennium Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Johnson Johnson Pharmaceutical Research Development LLC | INDUSTRY |